Indivior Pharmaceuticals (INDV) Invested Capital (2021 - 2025)
Indivior Pharmaceuticals (INDV) posted quarterly Invested Capital of $29.0 million for Q4 2025, up 61.11% year-over-year from $18.0 million in Q4 2024, and up 61.11% quarter-over-quarter from $18.0 million in Q3 2025.
Indivior Pharmaceuticals (INDV) Invested Capital (2021 - 2025) Analysis & Trends
Indivior Pharmaceuticals' Invested Capital history runs 5 years deep, the most recent figure standing at $29.0 million for Q4 2025.
- In Q4 2025, Invested Capital rose 61.11% year-over-year to $29.0 million; the TTM figure through Mar 2026 stood at $65.0 million (up 80.56% YoY), while the FY2025 annual figure was $29.0 million, up 61.11% from the prior year.
- Invested Capital for Q4 2025 stood at $29.0 million, up from $18.0 million in the prior quarter.
- The five-year high for Invested Capital was $324.0 million in Q4 2022, with the low at $18.0 million in Q4 2024.
- The 5-year median for Invested Capital is $23.5 million (2024), against an average of $131.5 million.
- The sharpest annual moves came in 2024 and 2025: Invested Capital tumbled 94.21% in 2024, then jumped 61.11% in 2025.
- Indivior Pharmaceuticals' Invested Capital stood at $316.0 million in 2021, then gained by 2.53% to $324.0 million in 2022, then retreated by 4.01% to $311.0 million in 2023, then sank by 94.21% to $18.0 million in 2024, then surged by 61.11% to $29.0 million in 2025.
- Business Quant data shows INDV's Invested Capital at $29.0 million in Q4 2025, $18.0 million in Q3 2025, and $18.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 630.00 Mn |
| 10 | Indivior Pharmaceuticals | 4.54 Bn | 4.31 Bn | 294.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.00 Mn |
| Sep 30, 2025 | 18.00 Mn |
| Jun 30, 2025 | 18.00 Mn |
| Mar 31, 2025 | 18.00 Mn |
| Dec 31, 2024 | 18.00 Mn |
| Dec 31, 2023 | 311.00 Mn |
| Dec 31, 2022 | 324.00 Mn |
| Dec 31, 2021 | 316.00 Mn |